Roth Capital lowered the firm’s price target on Brown-Forman (BF.B) to $35 from $38 and keeps a Buy rating on the shares after its Q4 results. The company closed FY25 with organic growth contraction following expansion in Q3 and 160bps of gross margin erosion after expansion in Q3, the analyst tells investors in a research note. Brown-Forman’s challenging environment is expected to continue, weighing on first FY26 guidance that calls for negative low single digit organic net sales and operating income growth, the firm added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BF.B:
Disclaimer & DisclosureReport an Issue